Spinnaker Trust decreased its position in shares of Bristol-Myers Squibb ( NYSE:BMY – Get Rating ) by 0.6% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 32,641 shares of the biopharmaceutical company's stock after selling 198 shares during the quarter. Spinnaker Trust's holdings in Bristol-Myers Squibb were worth $2,262,000 as of its most recent SEC filing. Other institutional investors and hedge funds have also recently modified their holdings of the company.

https://www.dailypolitical.com/2023/06/23/bristol-myers-squibb-nysebmy-shares-sold-by-spinnaker-trust.html

#dailypolitical